VINCERX PHARMA INC (VINC) Stock Analyst Ratings
USA - NASDAQ:VINC - US92731L3042 - Common Stock
0.1 USD
-0.03 (-24.98%)
0.0639 USD
-0.04 (-36.1%)
ChartMill assigns a Buy % Consensus number of 83% to VINC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 204. This target is 203900% above the current price.
VINC was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VINC.
In the previous month the buy percentage consensus was at a similar level.
VINC was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-08 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-04-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-04-01 | Cantor Fitzgerald | Reiterate | Overweight |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2022-11-17 | Chardan Capital | Maintains | Buy |
| 2022-08-12 | SVB Leerink | Maintains | Outperform |
| 2022-06-08 | Cantor Fitzgerald | Maintains | Overweight |
| 2022-06-07 | Chardan Capital | Maintains | Buy |
| 2022-06-07 | B. Riley Securities | Maintains | Buy |
| 2022-06-07 | SVB Leerink | Maintains | Outperform |
| 2022-05-13 | Chardan Capital | Maintains | Buy |
| 2022-05-13 | SVB Leerink | Maintains | Outperform |
| 2022-01-14 | HC Wainwright & Co. | Initiate | Buy |
| 2021-12-23 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-11-01 | SVB Leerink | Initiate | Outperform |
| 2021-09-13 | Laidlaw & Co. | Initiate | Buy |
| 2021-08-25 | B. Riley Securities | Initiate | Buy |
| 2021-08-13 | Chardan Capital | Maintains | Buy |
VINCERX PHARMA INC / VINC FAQ
What is the price target for VINC stock?
7 analysts have analysed VINC and the average price target is 204 USD. This implies a price increase of 203900% is expected in the next year compared to the current price of 0.1.
What is the consensus rating for VINCERX PHARMA INC (VINC) stock?
The consensus rating for VINCERX PHARMA INC (VINC) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed VINCERX PHARMA INC (VINC)?
The number of analysts covering VINCERX PHARMA INC (VINC) is 7.